scholarly journals Complete Heart Block as a Clinical Feature in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients: A Case Series of Three Cases

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Farook Ahmad ◽  
Priti Gandre ◽  
Julien Nguekam ◽  
Alanna Wall ◽  
ShiYu Ong ◽  
...  
Keyword(s):  
Respiratory Failure ◽  
Medical History ◽  
Critically Ill ◽  
Heart Block ◽  
Complete Heart Block ◽  
Case Series ◽  
Coronary Syndrome ◽  
Cardiovascular Morbidity And Mortality ◽  
Hypoxic Respiratory Failure ◽  
New Onset

Background. Novel coronavirus-19 disease (COVID-19) is associated with significant cardiovascular morbidity and mortality. However, there have been very few reports on complete heart block (CHB) associated with COVID-19. This case series describes clinical characteristics, potential mechanisms, and short-term outcomes of critically ill COVID-19 patients complicated by CHB. Case Summary. We present three cases of new-onset CHB in critically ill COVID-19 patients. Patient 1 is a 41-year-old male with well-documented history of Familial Mediterranean Fever (FMF) who required mechanical ventilator support for acute hypoxic respiratory failure from severe COVID-19 pneumonia. He developed new-onset CHB without a hemodynamic derangement but subsequently had acute coronary syndrome complicated by cardiogenic shock. Patient 2 is a 77-year-old male with no past medical history who required intubation for severe COVID-19 pneumonia acute hypoxic respiratory failure. He developed CHB with sinus pause requiring temporary pacing but subsequently developed multiorgan failure. Patient 3 is 36-year-old lady 38 + 2 weeks pregnant, gravida 2 para 1 with no other medical history, who had an emergency Lower Section Caesarean Section (LSCS) as she required intubation for acute hypoxic respiratory failure. She exhibited new-onset CHB without hemodynamic compromise. The CHB resolved spontaneously after 24 hours. Discussion. COVID-19-associated CHB is a very rare clinical manifestation. The potential mechanisms for CHB in patients with COVID-19 include myocardial inflammation or direct viral infiltration as well as other causes such as metabolic derangements or use of sedatives. Patients diagnosed with COVID-19 should be monitored closely for the development of bradyarrhythmia and hemodynamic instability.

scholarly journals Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series

2020 ◽  
Vol 4 (FI1) ◽  
pp. 1-6 ◽  
Author(s):  
Graham Peigh ◽  
Marysa V Leya ◽  
Jayson R Baman ◽  
Eric P Cantey ◽  
Bradley P Knight ◽  
...  
Keyword(s):  
Respiratory Failure ◽  
Medical History ◽  
Sinus Bradycardia ◽  
Sinus Node ◽  
Case Series ◽  
Sinus Node Dysfunction ◽  
Past Medical History ◽  
Hypoxic Respiratory Failure ◽  
Novel Coronavirus ◽  
New Onset

Abstract Background Novel coronavirus-19 disease (COVID-19) is associated with significant cardiovascular morbidity and mortality. To date, there have not been reports of sinus node dysfunction (SND) associated with COVID-19. This case series describes clinical characteristics, potential mechanisms, and short-term outcomes of COVID-19 patients who experience de novo SND. Case summary We present two cases of new-onset SND in patients recently diagnosed with COVID-19. Patient 1 is a 70-year-old female with no major past medical history who was intubated for acute hypoxic respiratory failure secondary to COVID-19 pneumonia and developed new-onset sinus bradycardia without a compensatory increase in heart rate in response to relative hypotension. Patient 2 is an 81-year-old male with a past medical history of an ascending aortic aneurysm, hypertension, and obstructive sleep apnoea who required intubation for COVID-19-induced acute hypoxic respiratory failure and exhibited new-onset sinus bradycardia followed by numerous episodes of haemodynamically significant accelerated idioventricular rhythm. Two weeks following the onset of SND, both patients remain in sinus bradycardia. Discussion COVID-19-associated SND has not previously been described. The potential mechanisms for SND in patients with COVID-19 include myocardial inflammation or direct viral infiltration. Patients diagnosed with COVID-19 should be monitored closely for the development of bradyarrhythmia and haemodynamic instability.

Prenatal diagnosis of congenital complete heart block — A case series

2008 ◽  
Vol 84 ◽  
pp. S153-S154
Author(s):  
Sofia Granja ◽  
Patrícia Costa ◽  
Ana Carriço ◽  
Cláudia Moura ◽  
José Monterroso ◽  
...  
Keyword(s):  
Prenatal Diagnosis ◽  
Heart Block ◽  
Complete Heart Block ◽  
Case Series ◽  
Congenital Complete Heart Block

scholarly journals Fetal heart rate tracing interpretation in cases of fetal heart block: A case series

2021 ◽  
Author(s):  
Fuanglada Tongprasert ◽  
Kasemsri Srisupundit ◽  
Suchaya Leuwan ◽  
Kuntharee Traisrisilp ◽  
Phudit Jatavan ◽  
...  
Keyword(s):  
Heart Rate ◽  
Vaginal Delivery ◽  
Fetal Heart Rate ◽  
Heart Block ◽  
Fetal Heart ◽  
Complete Heart Block ◽  
Case Series ◽  
Fetal Surveillance ◽  
Degree Heart Block ◽  
Second Degree

Simple assessment of FHR baseline variability can differentiate second degree heart block (SHB) from complete heart block (CHB). In cases of SHB, antepartum NST can be reliably used for fetal surveillance. Intrapartum assessment of FHR variability as well as accelerations is useful to select cases for safe vaginal delivery

scholarly journals Predictors for New-Onset Complete Heart Block After Transcatheter Aortic Valve Implantation

2010 ◽  
Vol 3 (5) ◽  
pp. 524-530 ◽  
Author(s):  
Sabine Bleiziffer ◽  
Hendrik Ruge ◽  
Jürgen Hörer ◽  
Andrea Hutter ◽  
Sarah Geisbüsch ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Heart Block ◽  
Complete Heart Block ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation ◽  
New Onset

Transcatheter closure of perimembranous ventricular septal defects with ductal occluders

2014 ◽  
Vol 25 (5) ◽  
pp. 918-926 ◽  
Author(s):  
Jayaranganath Mahimarangaiah ◽  
Anand Subramanian ◽  
Srinivasa Kikkeri Hemannasetty ◽  
Subhash Chandra ◽  
Satish Karur ◽  
...  
Keyword(s):  
Patent Ductus Arteriosus ◽  
Tricuspid Regurgitation ◽  
Heart Block ◽  
Complete Heart Block ◽  
Ductus Arteriosus ◽  
Amplatzer Duct Occluder ◽  
Ventricular Septal Defects ◽  
Septal Defects ◽  
Patent Ductus ◽  
New Onset

AbstractBackground: To study the feasibility and complications associated with the use of ductal occluders for closure of perimembranous ventricular septal defects. Methods: A total of 126 patients, ranging from 1 to 41 years of age (median – 8 years), underwent closure of ventricular septal defects from August 2010 to April 2013. Small- and moderate-sized defects were closed using first-generation Patent ductus arteriosus occluders or Amplatzer Duct Occluder-II. Patients were followed up for the development of complications such as heart block, aortic regurgitation, and tricuspid regurgitation. Results: Patent ductus arteriosus occluders were used in 81 patients, and the Amplatzer Duct Occluder-II device in 45 patients. The devices were successfully deployed in 99.2% of the cases. One patient had embolisation of an Amplatzer Duct Occluder-II device soon after deployment. There was one case of transient complete heart block (0.8%) needing temporary pacing, and two cases of isoarrhythmic atrioventricular dissociation (1.6%). One patient developed late-onset complete heart block 15 months after the procedure and underwent permanent pacemaker implantation. There were no instances of new-onset aortic regurgitation. New-onset mild tricuspid regurgitation was seen in two patients. Of the patients, three had small residual shunts on follow-up, without haemolysis. Conclusions: Duct occluders can be used to effectively close small- and moderate-sized ventricular septal defects. The incidence of complete heart block and valvular regurgitations are much less than reported with other devices, and they are cost-effective.

scholarly journals Complete Heart Block and Persistent Lactic Acidosis as an Initial Presentation of Non-Hodgkin Lymphoma in a Critically Ill Newly Diagnosed AIDS Patient

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
Mohsin Ijaz ◽  
Hassan Tariq ◽  
Masooma Niazi ◽  
Dmitry Lvovsky
Keyword(s):  
Lactic Acidosis ◽  
Hodgkin Lymphoma ◽  
Critically Ill ◽  
Heart Block ◽  
Complete Heart Block ◽  
Previous History ◽  
B Cell Lymphoma ◽  
Initial Presentation ◽  
Newly Diagnosed ◽  
Non Hodgkin Lymphoma

A 66-year-old male with newly diagnosed untreated acquired immunodeficiency syndrome (AIDS) presented with chronic nonspecific complaints of weakness, fatigue, myalgia, and weight loss. His initial EKG showed complete heart block necessitating temporary pacemaker placement. He had no previous history of cardiac disease. He was also found to have a persistent lactic acidosis and imaging studies showed abdominal lymphadenopathy. The patient underwent biopsy of these lymph nodes and was found to have diffuse large B-cell lymphoma. The hospital course was complicated by respiratory failure requiring mechanical ventilator support and cardiac arrest. Patient remained critically ill; he was not a candidate for chemotherapy and, after a month of hospitalization, he died. Lactic acidosis and heart block as an initial presentation of non-Hodgkin lymphoma in an AIDS patient are an unusual and unique presentation.

scholarly journals SACCULAR CORONARY ANEURYSM PRESENTING AS ACUTE CORONARY SYNDROME WITH ATRIAL FLUTTER AND COMPLETE HEART BLOCK

2019 ◽  
Vol 73 (9) ◽  
pp. 2397
Author(s):  
Jorge Andre Rodriguez-Lozano ◽  
Syed Gilani ◽  
Luba Frank ◽  
Joseph Hornak ◽  
Lin Gao ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Atrial Flutter ◽  
Heart Block ◽  
Complete Heart Block ◽  
Coronary Aneurysm ◽  
Coronary Syndrome
Sign in / Sign up

Export Citation Format

Share Document